Advertisement

Habitual consumption of soy protein and isoflavones and risk of metabolic syndrome in adults ≥ 40 years old: a prospective analysis of the Korean Multi-Rural Communities Cohort Study (MRCohort)

  • Hye Won Woo
  • Mi Kyung Kim
  • Young-Hoon Lee
  • Dong Hoon Shin
  • Min-Ho Shin
  • Bo Youl Choi
Original Contribution
  • 74 Downloads

Abstract

Purpose

Although considerable attention has been paid to the potential benefits of soy protein and isoflavones for preventing metabolic syndrome (MetS) and its components, findings linking habitual consumption of these factors to MetS are limited. This study aimed to evaluate the association of MetS incidence with habitual intake of soy protein/isoflavones among Korean men and women aged ≥ 40 years old who did not have MetS at baseline (n = 5509; 2204 men and 3305 women).

Methods

Dietary intake of soy protein/isoflavones at baseline and average consumption during follow-up were used.

Results

A significant inverse association between dietary intake and incidence of MetS was found in women (incidence rate ratios, IRR = 0.60, 95% CI = 0.46–0.78, P for trend = 0.0094 for the highest quintile of average soy protein intake compared with the lowest quintile; IRR = 0.57, 95% CI = 0.44–0.74, P for trend = 0.0048 for the highest quintile of average isoflavones intake compared with the lowest quintile). A tendency towards an inverse association was also found in men, although it was not significant for the highest quintile (IRR = 0.80, 95% CI = 0.58–1.11, P for trend = 0.9759, comparing the lowest to the highest quintile of average soy protein intake; IRR = 0.73, 95% CI = 0.53–1.01, P for trend = 0.8956, comparing the lowest to the highest quintile of average isoflavones intake). In terms of individual abnormalities, a significant inverse association was found between soy protein and isoflavones and the incidence of low–high-density lipoprotein cholesterol in both men and women. Abdominal obesity and elevated blood pressure were inversely related to soy protein/isoflavones only in women, and an inverse association of elevated triglyceride appeared only in men.

Conclusion

Our findings suggest that habitual intake of soy protein and isoflavones is inversely associated with the risk of MetS and its components. There is likely to be a reverse J-shaped association of average intake with MetS.

Keywords

Soy protein Isoflavones Metabolic syndrome Prospective Korea 

Abbreviations

BP

Blood pressure

BMI

Body mass index

CVD

Cardiovascular disease

CI

Confidence interval

CHD

Coronary heart disease

DQI-I

Diet quality index-international

FBG

Fasting blood glucose

FFQ

Food-frequency questionnaire

GLM

General linear model

HDL-C

High-density lipoprotein cholesterol

IRR

Incidence rate ratio

KoGES

Korean Genome and Epidemiology Study

MRCohort

Multi-rural Communities Cohort

Q

Quintiles

SD

Standard deviation

SE

Standard error

TG

Triglyceride

WC

Waist circumference

Notes

Acknowledgements

This work was supported by a Research Program funded by the Korea Centers for Disease Control and Prevention (2004-E71004-00, 2005-E71011-00, 2006-E71009-00, 2007-E71002-00, 2008-E71004-00, 2009-E71006-00, 2010-E71003-00, 2011-E71002-00, 2012-E71007-00, 2013-E71008-00) and by a National Research Foundation of Korea grant funded by the Korean government (Ministry of Science, ICT & Future Planning), (no. 2016R1A2B2011352).

Author contributions

HWW contributed to the data analysis and wrote the manuscript. YHL, DHS, MHS, and BYC were involved in data collection and management. MKK designed the study and supervised all the aspects of its implementation. All the authors helped to conceptualize the study, interpret the findings, and review drafts of the manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standard

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (Institutional Review Board of Hanyang University, Chonnam University, and Keimyung University) and with the Helsinki Declaration of 1964, as revised in 2000. Informed consent was obtained from all subjects for being included in the study.

Supplementary material

394_2018_1833_MOESM1_ESM.docx (41 kb)
Supplemental Table 1. Age-adjusted consumption of food groups according to the quintiles (Q) of average soy protein and isoflavones consumption. Supplemental Table 2. Multivariable-adjusted IRRs and 95% CIs of MetS according to the quintiles of average spy protein/isoflavones consumption by follow-up frequency. Supplemental Table 3. Multivariable-adjusted IRRs and 95% CIs of MetS according to two follow-up assignment methods (DOCX 40 KB)

References

  1. 1.
    Velasquez MT, Bhathena SJ (2007) Role of dietary soy protein in obesity. Int J Med Sci 4(2):72–82CrossRefGoogle Scholar
  2. 2.
    Appel LJ (2003) The effects of protein intake on blood pressure and cardiovascular disease. Curr Opin Lipidol 14(1):55–59CrossRefGoogle Scholar
  3. 3.
    Vedavanam K, Srijayanta S, O’Reilly J, Raman A, Wiseman H (1999) Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phytother Res 13(7):601–608CrossRefGoogle Scholar
  4. 4.
    Torres N, Torre-Villalvazo I, Tovar AR (2006) Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders. J Nutr Biochem 17(6):365–373CrossRefGoogle Scholar
  5. 5.
    Taku K, Umegaki K, Sato Y, Taki Y, Endoh K, Watanabe S (2007) Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr 85(4):1148–1156CrossRefGoogle Scholar
  6. 6.
    Zhan S, Ho SC (2005) Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 81(2):397–408CrossRefGoogle Scholar
  7. 7.
    Erdman JW, Badger TM, Lampe JW, Setchell KD, Messina M (2004) Not all soy products are created equal: caution needed in interpretation of research results. J Nutr 134(5):1229S–1233SCrossRefGoogle Scholar
  8. 8.
    Yan Z, Zhang X, Li C, Jiao S, Dong W (2017) Association between consumption of soy and risk of cardiovascular disease: a meta-analysis of observational studies. Eur J Prev Cardiol 24(7):735–747.  https://doi.org/10.1177/2047487316686441 CrossRefPubMedGoogle Scholar
  9. 9.
    Ramdath DD, Padhi EM, Sarfaraz S, Renwick S, Duncan AM (2017) Beyond the cholesterol-lowering effect of soy protein: a review of the effects of dietary soy and its constituents on risk factors for cardiovascular disease. Nutrients.  https://doi.org/10.3390/nu9040324 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Villegas R, Gao Y-T, Yang G, Li H-L, Elasy TA, Zheng W, Shu XO (2008) Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women’s Health Study. Am J Clin Nutr 87(1):162–167CrossRefGoogle Scholar
  11. 11.
    Mueller NT, Odegaard AO, Gross MD, Koh W-P, Mimi CY, Yuan J-M, Pereira MA (2012) Soy intake and risk of type 2 diabetes mellitus in Chinese Singaporeans. Eur J Nutr 51(8):1033–1040CrossRefGoogle Scholar
  12. 12.
    Yang G, Shu X-O, Jin F, Zhang X, Li H-L, Li Q, Gao Y-T, Zheng W (2005) Longitudinal study of soy food intake and blood pressure among middle-aged and elderly Chinese women. Am J Clin Nutr 81(5):1012–1017CrossRefGoogle Scholar
  13. 13.
    Zhang X, Shu XO, Gao Y-T, Yang G, Li Q, Li H, Jin F, Zheng W (2003) Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J Nutr 133(9):2874–2878CrossRefGoogle Scholar
  14. 14.
    Kokubo Y, Iso H, Ishihara J, Okada K, Inoue M, Tsugane S (2007) Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese Populations The Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 116(22):2553–2562CrossRefGoogle Scholar
  15. 15.
    Nagata C, Takatsuka N, Shimizu H (2002) Soy and fish oil intake and mortality in a Japanese community. Am J Epidemiol 156(9):824–831CrossRefGoogle Scholar
  16. 16.
    Talaei M, Koh W-P, van Dam RM, Yuan J-M, Pan A (2014) Dietary soy intake is not associated with risk of cardiovascular disease mortality in Singapore Chinese adults. J Nutr 144(6):921–928CrossRefGoogle Scholar
  17. 17.
    Yu D, Zhang X, Xiang Y-B, Yang G, Li H, Fazio S, Linton M, Cai Q, Zheng W, Gao Y-T (2014) Association of soy food intake with risk and biomarkers of coronary heart disease in Chinese men. Int J Cardiol 172(2):e285CrossRefGoogle Scholar
  18. 18.
    van der Schouw YT, Kreijkamp-Kaspers S, Peeters PH, Keinan-Boker L, Rimm EB, Grobbee DE (2005) Prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk in Western women. Circulation 111(4):465–471CrossRefGoogle Scholar
  19. 19.
    McCullough ML, Peterson JJ, Patel R, Jacques PF, Shah R, Dwyer JT (2012) Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr 95(2):454–464CrossRefGoogle Scholar
  20. 20.
    Zamora-Ros R, Jiménez C, Cleries R, Agudo A, Sánchez M-J, Sánchez-Cantalejo E, Molina-Montes E, Navarro C, Chirlaque M-D, Huerta JM (2013) Dietary flavonoid and lignan intake and mortality in a Spanish cohort. Epidemiology 24(5):726–733CrossRefGoogle Scholar
  21. 21.
    Expert Panel on Detection E (2001) Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Jama 285(19):2486CrossRefGoogle Scholar
  22. 22.
    Samson SL, Garber AJ (2014) Metabolic syndrome. Endocrinol Metab Clin 43(1):1–23CrossRefGoogle Scholar
  23. 23.
    Ahn Y, Kwon E, Shim J, Park M, Joo Y, Kimm K, Park C, Kim D (2007) Validation and reproducibility of food frequency questionnaire for Korean genome epidemiologic study. Eur J Clin Nutr 61(12):1435–1441CrossRefGoogle Scholar
  24. 24.
    Yang YK, Kim JY, Kwon O (2012) Development of flavonoid database for commonly consumed foods by Koreans. Kor J Nutr 45(3):283–292CrossRefGoogle Scholar
  25. 25.
    Bhagwat S, Haytowitz DB, Holden JM (2008) USDA database for the isoflavone content of selected foods, release 2.0, vol 15. US Department of Agriculture, MarylandGoogle Scholar
  26. 26.
    The Korean Nutrition Society (2009) Food values. The Korean Nutrition Society, SeoulGoogle Scholar
  27. 27.
    Hu FB, Stampfer MJ, Rimm E, Ascherio A, Rosner BA, Spiegelman D, Willett WC (1999) Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 149(6):531–540CrossRefGoogle Scholar
  28. 28.
    Alberti KGMM, Zimmet P, Shaw J (2006) Metabolic syndrome—a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med 23(5):469–480CrossRefGoogle Scholar
  29. 29.
    Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, Kim DY, Kwon HS, Kim SR, Lee CB (2007) Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabet Res Clin Pract 75(1):72–80CrossRefGoogle Scholar
  30. 30.
    Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65(4):1220S–1228SCrossRefGoogle Scholar
  31. 31.
    Shin B-R, Choi Y-K, Kim H-N, Song S-W (2016) High dietary calcium intake and a lack of dairy consumption are associated with metabolic syndrome in obese males: the Korean National Health and Nutrition Examination Survey 2010 to 2012. Nutr Res 36(6):518–525.  https://doi.org/10.1016/j.nutres.2016.01.002 CrossRefPubMedGoogle Scholar
  32. 32.
    Woo HW, Choi BY, Kim MK (2016) Cross-sectional and longitudinal associations between egg consumption and metabolic syndrome in adults ≥ 40 years old: the Yangpyeong Cohort of the Korean Genome and Epidemiology Study (KoGES_Yangpyeong). PloS One 11(1):e0147729CrossRefGoogle Scholar
  33. 33.
    Kim S, Haines PS, Siega-Riz AM, Popkin BM (2003) The Diet Quality Index-International (DQI-I) provides an effective tool for cross-national comparison of diet quality as illustrated by China and the United States. J Nutr 133(11):3476–3484CrossRefGoogle Scholar
  34. 34.
    Callas PW, Pastides H, Hosmer DW (1998) Empirical comparisons of proportional hazards, poisson, and logistic regression modeling of occupational cohort data. Am J Ind Med 33(1):33–47CrossRefGoogle Scholar
  35. 35.
    Zou G (2004) A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 159(7):702–706CrossRefGoogle Scholar
  36. 36.
    MacMahon B, Pugh TF (1970) Epidemiology: principles and methods, principles and methods. Little, Brown & Co, BostonGoogle Scholar
  37. 37.
    Ryu C, Hong S (2015) R visualication, 1st edn. Insignt, South KoreaGoogle Scholar
  38. 38.
    Micha R, Wallace SK, Mozaffarian D (2010) Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus. Circulation 121(21):2271–2283CrossRefGoogle Scholar
  39. 39.
    Messina M, Nagata C, Wu AH (2006) Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 55(1):1–12CrossRefGoogle Scholar
  40. 40.
    Food and Agriculture Organization of the United Nations (FAO). Food balance sheets. Available at http://faostat3.fao.org/download/FB/FBS/E. Accessed Aug 2016
  41. 41.
    Messina M, Messina V, Setchell KD (1994) The simple soybean and your health. Avery Pub. Group, New YorkGoogle Scholar
  42. 42.
    Canada H (2012) Summary of Health Canada’s Assessment of a health claim about barley products and blood cholesterol lowering. Health Canada Ottawa, OttawaGoogle Scholar
  43. 43.
    Stein K (2000) FDA approves health claim labeling for foods containing soy protein. J Acad Nutr Diet 100(3):292Google Scholar
  44. 44.
    EFSA Panel on Dietetic Products N, Allergies (2010) Scientific opinion on the substantiation of a health claim related to soy protein and reduction of blood cholesterol concentrations pursuant to Article 14 of the Regulation (EC) No 1924/2006. EFSA J 8(7):14Google Scholar
  45. 45.
    Omoni AO, Aluko RE (2005) Soybean foods and their benefits: potential mechanisms of action. Nutr Rev 63(8):272–283CrossRefGoogle Scholar
  46. 46.
    Cope M, Erdman J Jr, Allison D (2008) The potential role of soyfoods in weight and adiposity reduction: an evidence-based review. Obes Rev 9(3):219–235CrossRefGoogle Scholar
  47. 47.
    Jenkins DJ, Kendall CW, Jackson CJ, Connelly PW, Parker T, Faulkner D, Vidgen E, Cunnane SC, Leiter LA, Josse RG (2002) Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 76(2):365–372.  https://doi.org/10.1093/ajcn/76.2.365 CrossRefPubMedGoogle Scholar
  48. 48.
    Yeung J, Yu TF (2003) Effects of isoflavones (soy phyto-estrogens) on serum lipids: a meta-analysis of randomized controlled trials. Nutr J 2:15.  https://doi.org/10.1186/1475-2891-2-15 CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Setchell KD, Brown NM, Lydeking-Olsen E (2002) The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132(12):3577–3584.  https://doi.org/10.1093/jn/132.12.3577 CrossRefPubMedGoogle Scholar
  50. 50.
    Wong JM, Kendall CW, Marchie A, Liu Z, Vidgen E, Holmes C, Jackson CJ, Josse RG, Pencharz PB, Rao AV, Vuksan V, Singer W, Jenkins DJ (2012) Equol status and blood lipid profile in hyperlipidemia after consumption of diets containing soy foods. Am J Clin Nutr 95(3):564–571.  https://doi.org/10.3945/ajcn.111.017418 CrossRefPubMedGoogle Scholar
  51. 51.
    Hong KW, Ko KP, Ahn Y, Kim CS, Park SJ, Park JK, Kim SS, Kim Y (2012) Epidemiological profiles between equol producers and nonproducers: a genomewide association study of the equol-producing phenotype. Genes Nutr 7(4):567–574.  https://doi.org/10.1007/s12263-012-0292-8 CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Yuan JP, Wang JH, Liu X (2007) Metabolism of dietary soy isoflavones to equol by human intestinal microflora—implications for health. Mol Nutr Food Res 51(7):765–781.  https://doi.org/10.1002/mnfr.200600262 CrossRefPubMedGoogle Scholar
  53. 53.
    Potter SM (1995) Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 125(3 Suppl):606S–611SPubMedGoogle Scholar
  54. 54.
    Velasquez MT, Bhathena SJ (2007) Role of dietary soy protein in obesity. Int J Med Sci 4(2):72CrossRefGoogle Scholar
  55. 55.
    Cano A, García-Pérez M, Tarín JJ (2010) Isoflavones and cardiovascular disease. Maturitas 67(3):219–226CrossRefGoogle Scholar
  56. 56.
    Bazuine M, van den Broek PJ, Maassen JA (2005) Genistein directly inhibits GLUT4-mediated glucose uptake in 3T3-L1 adipocytes. Biochem Biophys Res Commun 326(2):511–514CrossRefGoogle Scholar
  57. 57.
    Squadrito F, Altavilla D, Morabito N, Crisafulli A, D’Anna R, Corrado F, Ruggeri P, Campo GM, Calapai G, Caputi AP (2002) The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women. Atherosclerosis 163(2):339–347CrossRefGoogle Scholar
  58. 58.
    Setchell KD, Clerici C, Lephart ED, Cole SJ, Heenan C, Castellani D, Wolfe BE, Nechemias-Zimmer L, Brown NM, Lund TD (2005) S-equol, a potent ligand for estrogen receptor β, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr 81(5):1072–1079CrossRefGoogle Scholar
  59. 59.
    Pan A, Franco OH, Ye J, Demark-Wahnefried W, Ye X, Yu Z, Li H, Lin X (2008) Soy protein intake has sex-specific effects on the risk of metabolic syndrome in middle-aged and elderly Chinese. J Nutr 138(12):2413–2421CrossRefGoogle Scholar
  60. 60.
    Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, Yasuda K (2003) Association of blood pressure with intake of soy products and other food groups in Japanese men and women. Prev Med 36(6):692–697CrossRefGoogle Scholar
  61. 61.
    Nozue M, Shimazu T, Sasazuki S, Charvat H, Mori N, Mutoh M, Sawada N, Iwasaki M, Yamaji T, Inoue M, Kokubo Y, Yamagishi K, Iso H, Tsugane S (2017) Fermented soy product intake is inversely associated with the development of high blood pressure: the Japan Public Health Center-Based Prospective Study. J Nutr 147(9):1749–1756.  https://doi.org/10.3945/jn.117.250282 CrossRefPubMedGoogle Scholar
  62. 62.
    Yang G, Shu XO, Jin F, Zhang X, Li HL, Li Q, Gao YT, Zheng W (2005) Longitudinal study of soy food intake and blood pressure among middle-aged and elderly Chinese women. Am J Clin Nutr 81(5):1012–1017CrossRefGoogle Scholar
  63. 63.
    Willett W (2012) Nutritional epidemiology. OUP, OxfordCrossRefGoogle Scholar
  64. 64.
    Barbosa-Leiker C, Wright BR, Burns GL, Parks CD, Strand PS (2011) Longitudinal measurement invariance of the metabolic syndrome: is the assessment of the metabolic syndrome stable over time? Ann Epidemiol 21(2):111–117CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Preventive Medicine, College of MedicineHanyang UniversitySeoulSouth Korea
  2. 2.Institute for Health and SocietyHanyang UniversitySeoulSouth Korea
  3. 3.Department of Preventive Medicine and Institute of Wonkwang Medical ScienceWonkwang University School of MedicineIksanSouth Korea
  4. 4.Department of Preventive MedicineKeimyung University Dongsan Medical CenterDaeguSouth Korea
  5. 5.Department of Preventive MedicineChonnam National University Medical SchoolGwangjuSouth Korea

Personalised recommendations